brineura
biomarin international limited - cerliponase alfa - neuronale ceroid-lipofuscinoses - andere maagdarmkanaal en metabolisme producten, - brineura is geïndiceerd voor de behandeling van neuronale ceroid lipofuscinosis type 2 (cln2) ziekte, ook wel bekend als tripeptidyl peptidase 1 (tpp1) - deficiëntie,.
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromusculaire blokkade - alle andere therapeutische producten - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromusculaire blokkade - alle andere therapeutische producten - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromusculaire blokkade - alle andere therapeutische producten - omkering van neuromusculaire blokkade geïnduceerd door rocuronium of vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromusculaire blokkade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromusculaire blokkade - alle andere therapeutische producten - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
ariclaim
eli lilly nederland b.v. - duloxetine - diabetische neuropathieën - psychoanaleptics, - behandeling van diabetische perifere neuropathische pijn. ariclaim is geïndiceerd bij volwassenen.
duloxetine boehringer ingelheim
boehringer ingelheim international gmbh - duloxetine - diabetische neuropathieën - psychoanaleptics, - behandeling van diabetische perifere neuropathische pijn bij volwassenen.
padcev
astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastische middelen - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.